Onset timing of statin‐induced musculoskeletal adverse events and concomitant drug‐associated shift in onset timing of MAEs

To evaluate the onset timing of musculoskeletal adverse events (MAEs) that develop during statin monotherapy and to determine whether concomitant drugs used concurrently with statin therapy shifts the onset timing of MAEs. Cases in which statins (atorvastatin, rosuvastatin, simvastatin, lovastatin,...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Pharmacol Res Perspect
Huvudupphovsmän: Akimoto, Hayato, Negishi, Akio, Oshima, Shinji, Okita, Mitsuyoshi, Numajiri, Sachihiko, Inoue, Naoko, Ohshima, Shigeru, Kobayashi, Daisuke
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2018
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6220123/
https://ncbi.nlm.nih.gov/pubmed/30443347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.439
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk